PODCAST

Empowered Patient Podcast

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

health & fitness medicine

All Episodes

Medical App for Medication Management Supports...

Empowered Patient Podcast ·

2025/11/12

Anne Meneghetti, Executive Director of epocrates, is focused on medication management and providing tools for clinicians to better handle challenges from the increasing population of patients who take multiple drugs and are treating a wide variety of conditions. The epocrates app provides access to drug information, pill identification, checks for interactions, and calculates dosing, reducing medication errors and patient confusion. Polypharmacy patients are further at risk when they are taking

27:37

Medical App for Medication Management Supports...

Empowered Patient Podcast ·

2025/11/12

New Biologic Drug for Rare IgG4-Related Disease with...

Empowered Patient Podcast ·

2025/11/11

Dr. Adam Kilian, Director of the Rheumatology Fellowship Training Program at the St. Louis University School of Medicine, focuses on IgG4-related disease, a rare multi-organ disease that has only recently been recognized due to significant diagnostic challenges. The MITIGATE trial is a landmark study that demonstrated that the first FDA-approved treatment, UPLIZNA from Amgen, provides an effective, targeted, steroid-free therapy. The approval of this drug is driving awareness in the medical

21:10

New Biologic Drug for Rare IgG4-Related Disease with...

Empowered Patient Podcast ·

2025/11/11

Early Detection of Alzheimer's Disease Critical to...

Empowered Patient Podcast ·

2025/11/10

Dr. Thomas Wisniewski, Director of NYU Langone's Alzheimer's Disease Research Center, shares insights from a recent study that projects new dementia cases in the US will double by 2060. New diagnostic tools have made it easier to identify early signs of Alzheimer's, and disease-modifying therapies are being approved, which can be effective if patients are treated in the earliest stages of the disease. AI is seen as a tool to help identify at-risk patients and routinely screen patients to manage the

22:40

Early Detection of Alzheimer's Disease Critical to...

Empowered Patient Podcast ·

2025/11/10

Small Pediatric Practices Overcome Challenges of...

Empowered Patient Podcast ·

2025/11/07

Pedro Sanchez de Lozada, CEO of Canid, highlights the significant financial risks that pediatricians face in managing their vaccine inventory. There are administrative burdens associated with ordering, patient demand, tracking, reporting, and filing for insurance reimbursement. The Canid platform was designed to be a vaccine-as-a-service model, removing risk and administrative work from pediatric practices, allowing small and independent practices to achieve economies of scale, and freeing up more

24:04

Small Pediatric Practices Overcome Challenges of...

Empowered Patient Podcast ·

2025/11/07

Accelerating Access to Cell and Gene Therapies with...

Empowered Patient Podcast ·

2025/11/06

Alicia Silver, senior director at ADVI Health, highlights the evolving landscape of cell and gene therapy and the need to improve patient access and payment for these treatments. Availability of these therapies for solid tumors and genetic diseases like sickle cell disease is expanding due to the transition from inpatient to outpatient and community settings. The FDA's decision to remove REMS requirements for specific therapies has accelerated the growth of facilities to provide care, particularly

20:35

Accelerating Access to Cell and Gene Therapies with...

Empowered Patient Podcast ·

2025/11/06

DNA-Based Immunotherapy Poised to Transform Ovarian...

Empowered Patient Podcast ·

2025/11/05

Dr. Stacy Lindborg, President and CEO of IMUNON, has developed a DNA-based immunotherapy candidate for the treatment of ovarian cancer. This therapy works by administering the drug, which utilizes IL-12, a powerful anti-cancer cytokine, directly into the cavity where the cancer resides, thereby affecting the tumor microenvironment. Trials are showing that the drug can produce significant life extension when used in combination with standard chemotherapy. Stacy explains, "There are about 300,000

20:57

DNA-Based Immunotherapy Poised to Transform Ovarian...

Empowered Patient Podcast ·

2025/11/05

AI-Powered Movement-Based Medicine Platform with...

Empowered Patient Podcast ·

2025/11/04

Donovan Campbell, CEO of Medbridge, empowers clinicians through a platform that is focused on movement-based medicine and a holistic approach to patient care. MedBridge has developed AI tools to perform triage, act as a care coordinator, and serve as a patient-facing coach, offloading administrative tasks and providing better support to patients. These tools are designed to support clinicians by flagging potential issues and increasing patient engagement by delivering immediate digital access to

21:09

AI-Powered Movement-Based Medicine Platform with...

Empowered Patient Podcast ·

2025/11/04

Accessible Genetic Tests for Reproductive Carrier and...

Empowered Patient Podcast ·

2025/11/03

Dr. Matt Goldstein, CEO of jscreen, focuses on the importance and power of preventive genetic testing for reproductive carrier screening and hereditary cancer screening. All genetic tests include analysis to inform specific medical management plans and provide genetic counselors to explore options. Of particular interest is testing for the gene mutations that cause Tay-Sachs disease and helping families take proactive steps to effectively eliminate the disease in future generations. Matt explains,

20:26

Accessible Genetic Tests for Reproductive Carrier and...

Empowered Patient Podcast ·

2025/11/03

Significance of Regulatory RNA in Protein Production...

Empowered Patient Podcast ·

2025/10/31

Dr. Yuri Maricich, Chief Medical Officer at CAMP4 Therapeutics, describes regulatory RNA, a new area of biology that recognizes the role of Reg RNA in the production of proteins from specific genes. This technology is well-suited for haploinsufficient diseases such as SYNGAP1-related disorders, in which there is a lack of healthy protein and both parents carry a copy of the mutated gene. The goal is to create disease-modifying treatments that correct the underlying genetic cause rather than treating

18:46

Significance of Regulatory RNA in Protein Production...

Empowered Patient Podcast ·

2025/10/31

DNA Immunotherapy Shows Durable Response in Advanced...

Empowered Patient Podcast ·

2025/10/30

Phil L'Huillier, CEO of Scancell, has developed an off-the-shelf DNA immunotherapy designed to generate a potent and durable immune response against advanced melanoma in patients who are unresponsive to current therapies. Their lead candidate showed significant benefit when added to standard of care checkpoint inhibitors, improving duration of response without adding side effects or toxicity. Patient selection in future trials will use a blood test to identify the immune types that can be expected

23:49

DNA Immunotherapy Shows Durable Response in Advanced...

Empowered Patient Podcast ·

2025/10/30

2,491 results

Empowered Patient Podcast

All Episodes

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown